A citation-based method for searching scientific literature


List of co-cited articles
96 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.
Michael Elashoff, Aleksey V Matveyenko, Belinda Gier, Robert Elashoff, Peter C Butler. Gastroenterology 2011
549
47


Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin.
Aleksey V Matveyenko, Sarah Dry, Heather I Cox, Artemis Moshtaghian, Tatyana Gurlo, Ryan Galasso, Alexandra E Butler, Peter C Butler. Diabetes 2009
183
31


A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?
Peter C Butler, Michael Elashoff, Robert Elashoff, Edwin A M Gale. Diabetes Care 2013
193
26

Pancreatic safety of incretin-based drugs--FDA and EMA assessment.
Amy G Egan, Eberhard Blind, Kristina Dunder, Pieter A de Graeff, B Timothy Hummer, Todd Bourcier, Curtis Rosebraugh. N Engl J Med 2014
325
26

Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies.
S Bonner-Weir, P A In't Veld, G C Weir. Diabetes Obes Metab 2014
43
21

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
21

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
21


Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.
Sonal Singh, Hsien-Yen Chang, Thomas M Richards, Jonathan P Weiner, Jeanne M Clark, Jodi B Segal. JAMA Intern Med 2013
260
21




GLP1 and cancer: friend or foe?
Roman Vangoitsenhoven, Chantal Mathieu, Bart Van der Schueren. Endocr Relat Cancer 2012
35
21


Risk of pancreatitis in patients treated with incretin-based therapies.
Juris J Meier, Michael A Nauck. Diabetologia 2014
68
15



Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis.
S S Engel, D E Williams-Herman, G T Golm, R J Clay, S V Machotka, K D Kaufman, B J Goldstein. Int J Clin Pract 2010
112
15

Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population.
John A Romley, Dana P Goldman, Matthew Solomon, Daniel McFadden, Anne L Peters. Diabetes Technol Ther 2012
63
15

The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species.
Niels C B Nyborg, Anne-Marie Mølck, Lars W Madsen, Lotte Bjerre Knudsen. Diabetes 2012
104
15

Occurrence of spontaneous pancreatic lesions in normal and diabetic rats: a potential confounding factor in the nonclinical assessment of GLP-1-based therapies.
Kristina D Chadwick, Anthony M Fletcher, M Cecilia Parrula, Susan Bonner-Weir, Raja S Mangipudy, Evan Janovitz, Michael J Graziano, Denis Roy, Timothy P Reilly. Diabetes 2014
23
15

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents.
Krystyna Tatarkiewicz, Pamela A Smith, Emmanuel J Sablan, Clara J Polizzi, Donald E Aumann, Christiane Villescaz, Diane M Hargrove, Bronislava R Gedulin, Melissa G W Lu, Lisa Adams,[...]. Am J Physiol Endocrinol Metab 2010
77
15

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies.
Ling Li, Jiantong Shen, Malgorzata M Bala, Jason W Busse, Shanil Ebrahim, Per Olav Vandvik, Lorena P Rios, German Malaga, Evelyn Wong, Zahra Sohani,[...]. BMJ 2014
142
15

No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks.
K Tatarkiewicz, P Belanger, G Gu, D Parkes, D Roy. Diabetes Obes Metab 2013
40
15

One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice.
Kathryn Aston-Mourney, Shoba L Subramanian, Sakeneh Zraika, Thanya Samarasekera, Daniel T Meier, Lynn C Goldstein, Rebecca L Hull. Am J Physiol Endocrinol Metab 2013
30
15

GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Charles Pyke, R Scott Heller, Rikke K Kirk, Cathrine Ørskov, Steffen Reedtz-Runge, Peter Kaastrup, Anders Hvelplund, Linda Bardram, Dan Calatayud, Lotte Bjerre Knudsen. Endocrinology 2014
401
15

Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study.
M Gokhale, J B Buse, C L Gray, V Pate, M A Marquis, T Stürmer. Diabetes Obes Metab 2014
52
15

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.
Laurent Azoulay, Kristian B Filion, Robert W Platt, Matthew Dahl, Colin R Dormuth, Kristin K Clemens, Madeleine Durand, David N Juurlink, Laura E Targownik, Tanvir C Turin,[...]. BMJ 2016
64
15

Glucagon-like peptide-1, glucose homeostasis and diabetes.
Jens J Holst, Carolyn F Deacon, Tina Vilsbøll, Thure Krarup, Sten Madsbad. Trends Mol Med 2008
111
10

Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS.
L van Bloemendaal, J S Ten Kulve, S E la Fleur, R G Ijzerman, M Diamant. J Endocrinol 2014
130
10


Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2012
10


Metabolic adaptations of three inbred strains of mice (C57BL/6, DBA/2, and 129T2) in response to a high-fat diet.
Alexandra Funkat, Christine M Massa, Valentina Jovanovska, Joseph Proietto, Sofianos Andrikopoulos. J Nutr 2004
67
10

A primary defect in glucose production alone cannot induce glucose intolerance without defects in insulin secretion.
Salvatore P Mangiafico, Shueh H Lim, Sandra Neoh, Helene Massinet, Christos N Joannides, Joseph Proietto, Sofianos Andrikopoulos, Barbara C Fam. J Endocrinol 2011
11
18

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth.
Yin-Hsun Feng, Guermarie Velazquez-Torres, Christopher Gully, Jian Chen, Mong-Hong Lee, Sai-Ching Jim Yeung. J Cell Mol Med 2011
65
10

Acute pancreatitis due to diabetes: the role of hyperglycaemia and insulin resistance.
Nicholas S Solanki, Savio G Barreto, Gino T P Saccone. Pancreatology 2012
32
10


Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials.
Matteo Monami, Ilaria Dicembrini, Daniele Martelli, Edoardo Mannucci. Curr Med Res Opin 2011
155
10

Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database.
Jean-Luc Faillie, Samy Babai, Sabrina Crépin, Virginie Bres, Marie-Laure Laroche, Hervé Le Louet, Pierre Petit, Jean-Louis Montastruc, Dominique Hillaire-Buys. Acta Diabetol 2014
51
10

Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study.
Carlo B Giorda, Roberta Picariello, Elisa Nada, Barbara Tartaglino, Lisa Marafetti, Giuseppe Costa, Roberto Gnavi. Lancet Diabetes Endocrinol 2014
33
10

Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies.
Qiwen Ben, Maojin Xu, Xiaoyan Ning, Jun Liu, Shangyou Hong, Wen Huang, Huagao Zhang, Zhaoshen Li. Eur J Cancer 2011
380
10





Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study.
Jean-Luc Faillie, Laurent Azoulay, Valerie Patenaude, Dominique Hillaire-Buys, Samy Suissa. BMJ 2014
56
10

A cohort study of acute pancreatitis in relation to exenatide use.
D D Dore, G L Bloomgren, M Wenten, C Hoffman, C R Clifford, S G Quinn, D K Braun, R A Noel, J D Seeger. Diabetes Obes Metab 2011
115
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.